1 NAADAC and NBCC CEHs

Available Certificates will be mailed within 15 business days.

June 21, 2016 @ 1PM EST

 Recovery-Oriented Tobacco Interventions in Addiction Services 

Presenter: Tony Klein, MPA, NCACII

Stopping tobacco concurrently with other substances improves the quality of drug treatment, reduces the incidence of drug relapse and enhances overall drug recovery.  The challenge is to determine how to best implement evidence-based tobacco treatment in addiction services while promoting change to prevailing social norms that uphold tobacco use behavior among individuals with substance use disorders. This presentation utilizes research data and the lessons learned from New York State Promising Tobacco Interventions Projects to examine the bio-psycho-social aspects of tobacco use specific to this clinical population. The discussion will focus on practical strategies for an integrated tobacco intervention model delivered within the spirit of drug recovery, cultural adaptation of evidence-based practice guidelines; and a systems approach to policy development.

CLICK HERE TO REGISTER


July 19, 2016 @ 1PM EST

 Electronic Nicotine Devices

Presenter: Phillip Gardiner, DrPH 

More Information to Come


August 23, 2016 @ 1PM EST

 Using Motivational Incentives in Tobacco Treatment 

Presenter: Elizabeth Sysak

More Information to Come


August 18, 2015 @ 1PM EST

 Reaching, Motivating, and Treating Low SES Smokers 

Presenter: Dr. Bruce Christiansen

This presentation begins with a historical look at low SES tobacco disparity using education as a proxy measure for low SES. This historical look emphasizes the role tobacco control policies may have had in the emergence of this disparity. Examples of unintended consequences of tobacco control efforts are provided. Three broad categories of responses to address this disparity are considered: do nothing, increase outreach to the target population, and tailoring to this population.  Regarding this latter, examples of tailoring are provided. Finally, a series of research studies is used to demonstrate tailoring of treatment and setting.  

CLICK HERE TO VIEW PRESENTATION SLIDES


GBT Health Disparities: Opportunities for Engagement 

PresenterMr. Juan Carlos Vega

With LGBT Pride month events and festivals happening all over the country, we invite you to learn about how to ensure your tobaco and cancer control and prevention work is reaching and serving the Lesbian, Gay, Bisexual & Transgender (LGBT) communities. In this webinar, Mr. Vega will discuss the following topics:  (1) An overview of LGBT people and related health disparities; (2) Strategies for ensuring your activities and services reach the LGBT populations; (3) Best and promising practices and other resources for inclusion.  

CLICK HERE TO VIEW PRESENTATION SLIDES


May 19, 2015 @ 1PM EST

 Updates in Tobacco Use Among People with Severe and Persistent Mental Illness 

PresenterDr. Debra Hrouda

With webinar will help participants advance tobacco recovery among behavioral health clients. It will focus on the unique interplay between tobacco, severe mental illness, substance-related conditions, other physical health conditions, and psychotropic medications.  Attendees will learn the different treatment approaches to help clients reduce and/or eliminate tobacco use: psychosocial interventions as well as appropriate use of nicotine replacement therapies and medications known to help people quit tobacco will be presented. Behavioral health providers are in a great position to intervene with tobacco effectively.

CLICK HERE TO VIEW PRESENTATION SLIDES


 

February 10, 2015 @ 1PM EST

 Updates in Tobacco Dependence Treatment

PresenterDr. Jill Williams 

Despite the alarming statistics, people with mental illnesses or other addictions have less access to tobacco dependence treatment across the health care spectrum.  Many studies have found that not enough is being done in behavioral health settings to treat tobacco.  Assessment of tobacco dependence is important for guiding treatment as with any clinical problem. Higher levels of tobacco dependence result in more severe withdrawal symptoms and greater difficulty in quitting. Dependent smokers are therefore likely to require more intensive behavioral and pharmacological interventions to help them succeed in a quit attempt. Research supports that medications are effective in reducing nicotine withdrawal symptoms and at least doubling the smoker’s chance of success in quitting smoking. Nicotine withdrawal causes symptoms of agitation, anxiety, restlessness, and impaired concentration that can mimic symptoms of psychiatric illness.  Practice guidelines indicate that all smokers trying to quit should use pharmacotherapy as a first-line treatment.  Review of clinical practice however suggests that use is much less; fewer than one out of every 3 smokers who try to quit use an FDA-approved smoking cessation medicine.  Pharmacotherapy may be even more important to smokers with mental illness as they have higher levels of nicotine dependence than other smokers.  In this webinar, Dr. Williams will discuss the following topics: (1) The FDA approved medications for treating tobacco dependence including dosing, common side effects, and mechanisms of action; (2) Research studies of tobacco treatment medications that have been used to help behavioral health populations quit smoking


 

January 20, 2015 @ 1PM EST

"How" - Integrating Tobacco Treatment into Daily Practice

PresenterDr. Chad Morris

Community healthcare and hospital providers are increasingly aware of the tobacco-related health disparities faced by vulnerable populations such as smokers who are living in poverty or who have mental illnesses and addictions.  At the same time, healthcare reform and other federal and state mandates require that tobacco screening, assessment, treatment and referral are included in service offerings.  While many healthcare agencies are motivated to begin offering tobacco cessation services, many questions remain regarding how to effectively integrate these services into organizational daily practice. This presentation will provide practical strategies for implementing agency and clinic tobacco cessation services.  An agency workflow will be presented which describes staffing, roles and responsibilities.  Examples of treatment planning will be provided and strategies for aligning workflows and treatment planning with core electronic health record fields and billing strategies will be discussed.

CLICK HERE TO VIEW PRESENTATION SLIDES


 

December 16, 2014 @ PM EST

Electronic Cigarettes and Cessation: The Promise Verses Reality

PresenterPhillip Gardiner, DrPH 

We will continue our discussion of Electronic Cigarettes and Cessation. Electronic cigarettes have gained tremendous popularity over the past few years. Yet there is only partial information on the chemical composition and potential health benefits and or harm of these products. While harm reduction and cessation claims abound, the existing scientific ligature provides a cautionary tale that the use of theme products may lead to the ongoing use of both regular tobacco products and electronic cigarettes (dual use).  New studies confirm that 2nd hand aerosol is inhaled by the people near and around e-cigarette users.  This later fact has led a growing number of cities and locales to adopt legislation to regulate e-cigarette as tobacco products.  The FDA regulatory process has begun, but initial indications are that may not be as comprehensive as needed and could take upwards of 2 years to even enact.  And with the tobacco industry moving to the forefront of the e-cigarette industry, this reality coupled with the other concerns stated above should give all tobacco control activists pause and reason for concern.  The bottom line is that while e-cigarettes maybe safe then conventional cigarettes, that doesn't mean they are safe.

CLICK HERE TO VIEW PRESENTATION SLIDES


October 2014 

Electronic Cigarettes: The Vapor This Time? Precaution Advised

PresenterPhillip Gardiner, DrPH 

The use, sell and promotion of electronic cigarettes have increased dramatically over the past few years; many hailing them as the key thing to bring the cigarette epidemic to the end.  One thing is clear; no one knows what the impact of regularly smoking nicotine laced propylene glycol will have on one's health or the impact on the public's health over time.  However, a close examination will show that while there may be some potential to reduce the risks from smoking by the use of electronic cigarettes, there also, still many immediate hazards.  These products still emit volatile organic, tobacco specific carcinogens and other toxins, albeit in lower amounts than conventional cigarettes.  Moreover, with the advent of tank systems, studies are showing emission of carcinogens equaling and in some cases surpassing amounts in conventional cigarettes. 

CLICK HERE TO VIEW PRESENTATION SLIDES